INVERIME

Experience

Efficacy and Safety of a Novel Tetravalent Dengue Vaccine in Healthy Children and Adolescent Aged 9 to 16 years in Latin America. SanofiPasteur CYD 15 Protocol.

Immunogenicity and Safety of a Tetravalent Dengue Vaccine
given as a Booster Injection in Adolescents and Adults who
previously completed the 3-dose schedule in a study conducted in
Latin America. SanofiPasteur CYD64 Protocol.

Prospective Surveillance and Case Definition Study of Zika
Virus Disease and Infection in Adolescents and Adults in Latin
America in Preparation for an Efficacy Trial of a Zika Virus
Whole Virion, Purified Inactivated Vaccine. SanofiPasteur VAG00001 Protocol.

Disease areas

• Dengue
• Enteric diseases
• Influenza
• Respiratory Diseases
• Zika

Other information

This group has previous experience as ODISH:

Efficacy study of GSK Biologicals’ quadrivalent influenza vaccine, GSK2282512A, (FLU Q-QIV) when administered in children.

Immunogenicity, Efficacy and saffety of Oral Rotavirus Vaccine. GSK Biologicals Rota 023 Protocol.

Safety, efficacy and immunogenicity of a Human Papilloma Virus Vaccine. GSK Biologicals HPV 013 Protocol.

Epidemiological study to know the incidence of Rotavirus Gastroenteritis in the population under three years of age in the Tegucigalpa and Comayagüela area.

• Epidemiological study to know the incidence of Intestinal Invagination in the population under two years of age in the Tegucigalpa and Comayagüela area.

Media

Documents